Search results
Lipocine To Focus On Central Nervous System Conditions; Explores Partnerships For Non-Core Assets
Benzinga via Yahoo Finance· 2 years agoLipocine Inc (NASDAQ: LPCN) announced its plans to focus on treating Central Nervous System (CNS)...
Lipocine Posts Encouraging Data For Testosterone Prodrug In NASH Patients
Benzinga via Yahoo Finance· 2 years agoLipocine Inc (NASDAQ: LPCN) has announced topline results from its Open-Label Extension (OLE) study...
Is Lipocine Inc.'s (NASDAQ:LPCN) Stock's Recent Performance Being Led By Its Attractive Financial...
Simply Wall St. via Yahoo Finance· 1 year agoLipocine (NASDAQ:LPCN) has had a great run on the share market with its stock up by a significant...
Lipocine Inc. (NASDAQ:LPCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market...
Simply Wall St. via Yahoo Finance· 2 years agoLipocine (NASDAQ:LPCN) has had a rough week with its share price down 7.1%. But if you pay close...
Lipocine: Q1 Earnings Snapshot
AP Finance via Yahoo Finance· 12 months agoSALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Lipocine Inc. (LPCN) on Thursday reported a loss of $3.9 million in its first quarter. The Salt Lake City-based company said it had a loss of 4 cents ...
